Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oasmia Pharmaceutical AB
OASMYCurrent price
0.05 USD
0 USD (0.00%)
Last closed
0.05 USD
Company
www.oasmia.com
ISIN
US67421W1099
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
PINK
Capitalization
13 055 100 USD
Yield for 12 month
+24 900.00 %
1Y
3Y
5Y
10Y
15Y
OASMY
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Address: Gustav III:s Boulevard 46, Solna, Sweden, 169 73
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+61 579 USD
Last Year
+9 419 USD
Current Quarter
–
Last Quarter
–
Current Year
+17 797 USD
Last Year
-3 331 698 USD
Current Quarter
-7 020 USD
Last Quarter
-7 218 USD
Key Figures OASMY
1 year
3 years
5 years
10 years
EBITDA
-54 033 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.61 %
PEG Ratio
–
Return On Equity TTM
-43.42 %
Wall Street Target Price
6 USD
Revenue TTM
6 612 000 USD
Book Value
0.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
222.7 %
Dividend Yield
–
Gross Profit TTM
-2 289 000 USD
Earnings per share
-0.05 USD
Diluted Eps TTM
-0.05 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OASMY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-217 %Dividend History OASMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
25.03.2022
Forward Annual Dividend Yield
–
Last Split Factor
1673:1223
Payout Ratio
–
Last Split Date
15.11.2019
Dividend Date
04.04.2022
Stock Valuation OASMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.8677
Price Sales TTM
1.9745
Enterprise Value EBITDA
-0.1101
Price Book MRQ
0.5308
Financials OASMY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OASMY
For 52 weeks
0.0002 USD
0.05 USD
50 Day MA
0.05 USD
Shares Short Prior Month
11 075
200 Day MA
0.035 USD
Short Ratio
0.03
Shares Short
20 724
Short Percent
0.02 %
BeatStart